COMPASS Pathways plc (NASDAQ:CMPS) Receives Average Recommendation of “Buy” from Analysts

Shares of COMPASS Pathways plc (NASDAQ:CMPS) have earned a consensus recommendation of “Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. Six investment analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $33.60.

Several equities research analysts have commented on the stock. Maxim Group lowered their target price on shares of COMPASS Pathways from $22.00 to $12.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Royal Bank of Canada dropped their price objective on COMPASS Pathways from $23.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Cantor Fitzgerald reissued an “overweight” rating on shares of COMPASS Pathways in a research note on Monday, September 9th. Finally, HC Wainwright dropped their price target on COMPASS Pathways from $120.00 to $60.00 and set a “buy” rating on the stock in a research report on Friday, November 1st.

Institutional Trading of COMPASS Pathways

A number of institutional investors have recently modified their holdings of CMPS. Blue Trust Inc. acquired a new stake in COMPASS Pathways in the 2nd quarter valued at approximately $81,000. Green Alpha Advisors LLC bought a new position in shares of COMPASS Pathways during the 3rd quarter worth approximately $99,000. Y Intercept Hong Kong Ltd bought a new position in shares of COMPASS Pathways during the 3rd quarter worth approximately $131,000. Fore Capital LLC acquired a new stake in shares of COMPASS Pathways in the second quarter valued at approximately $181,000. Finally, Geode Capital Management LLC lifted its position in shares of COMPASS Pathways by 160.3% in the third quarter. Geode Capital Management LLC now owns 42,169 shares of the company’s stock worth $266,000 after purchasing an additional 25,970 shares in the last quarter. 46.19% of the stock is currently owned by institutional investors.

COMPASS Pathways Stock Up 2.7 %

Shares of COMPASS Pathways stock opened at $4.14 on Friday. The business has a fifty day simple moving average of $4.86 and a 200 day simple moving average of $6.13. The stock has a market cap of $283.26 million, a PE ratio of -1.88 and a beta of 2.25. The company has a quick ratio of 8.91, a current ratio of 8.91 and a debt-to-equity ratio of 0.15. COMPASS Pathways has a 12 month low of $3.86 and a 12 month high of $12.75.

COMPASS Pathways (NASDAQ:CMPS) last posted its earnings results on Thursday, October 31st. The company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.60) by $0.04. During the same period last year, the business earned ($0.67) EPS. Research analysts predict that COMPASS Pathways will post -2.33 EPS for the current year.

About COMPASS Pathways

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.